STAAR Surgical Company (STAA) Cash Flow Statement
STAAR Surgical Company (STAA) generated -$3.3M of operating cash flow over the twelve months to 2026-07-03, spent $3.5M on capital expenditure and had free cash flow of -$6.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
STAASTAAR Surgical CompanyFollow STAA — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Jan 14 | FY2014 Jan 15 | FY2015 Jan 16 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Jan 20 | FY2020 Jan 21 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.3 | 3.2 | 3.4 | -8.0 | -2.2 | 1.0 | 2.9 | 12.8 | 25.8 | 21.0 | 44.0 | 35.7 | 14.6 | 15.7 | -34.2 | -3.3 | |
| Capital expenditure | 1.0 | 2.3 | 3.4 | 4.1 | 2.0 | 3.2 | 1.0 | 2.2 | 10.1 | 8.4 | 13.6 | 18.1 | 18.2 | 23.4 | 5.8 | -3.5 | |
| Free cash flow | 4.4 | 0.9 | -0.1 | -12.0 | -4.2 | -2.2 | 1.8 | 10.5 | 15.7 | 12.5 | 30.3 | 17.6 | -3.6 | -7.7 | -40.1 | -6.7 | |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.5 | — | |
| Stock-based compensation | 1.9 | 3.2 | 4.5 | 4.7 | 3.3 | 8.6 | 3.2 | 6.8 | 10.5 | 12.1 | 14.6 | 20.4 | 23.5 | 27.2 | 30.6 | — |
USD millions · SEC XBRL
STAAR Surgical Company — questions
- What is STAAR Surgical Company's operating cash flow?
- -$3.3M over the twelve months to 2026-07-03.
- How much does STAAR Surgical Company spend on capital expenditure?
- $3.5M over the twelve months to 2026-07-03.
- What is STAAR Surgical Company's free cash flow?
- -$6.7M over the twelve months to 2026-07-03: operating cash flow minus capital expenditure.
Every figure on this page comes from STAAR Surgical Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.